Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project
CAMBRIDGE, Mass., July 31 /PRNewswire/ -- HIV/AIDS and health systems expert Ann Lion Coleman will join Abt Associates as Director for the Health Systems 20/20 project in August 2008. Health Systems 20/20 is the USAID Bureau of Global Health's flagship project working to strengthen health syst...Leading Health Economist, Dr. Hong Wang, Joins Abt Associates
Expert in International Health Economics and Financing and Health Policy Will Play Leading Role in Health Systems 20/20 Project CAMBRIDGE, Mass., July 14 /PRNewswire/ -- Abt Associates announced that Dr. Hong Wang, M.D., Ph.D., has joined the company as a Senior Health Economist workin...Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education
... U.S. House of Representatives Subcommittee on Research and Science Education, part of the larger Committee on Science and Technology, Abbott (NYSE: abt ) testified on its contributions as a private sector company in a multi-stakeholder, systems approach to improving kindergarten through 12th grade (K-...Abbott and Medtronic Reach Agreement on Global Patent Disputes
... ABBOTT PARK, Ill., July 27 /PRNewswire-FirstCall/ -- Abbott (NYSE: abt ) announced today a settlement resolving all outstanding intellectual property litigation between the two parties. Under the terms of the sett...New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer
...t technological advancements, including the development of the very first diagnostic test to detect HIV. About Abbott Abbott (NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents
... CHICAGO, July 21 /PRNewswire-FirstCall/ -- Abbott (NYSE: abt ) today unveiled its new PLEX-ID system currently in development for detecting and characterizing a wide range of pathogens, including infectious agen...Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers
... CHICAGO, July 21 /PRNewswire-FirstCall/ -- Today at the American Association for Clinical Chemistry's Clinical Lab Expo in Chicago, Abbott (NYSE: abt ) announced the launch of a new diagnostic instrument -- the ARCHITECT(R) c4000(R) clinical chemistry analyzer which performs diagnostic tests that mo...Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
... ABBOTT PARK, Ill., July 15 /PRNewswire-FirstCall/ -- Abbott (NYSE: abt ) today announced financial results for the second quarter ended June 30, 2009. Diluted earnings per share, excluding specified items, ...Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
... ABBOTT PARK, Ill., and WATERTOWN, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Abbott ( NYSE: abt ) and Enanta Pharmaceuticals announced today the advancement of their Hepatitis C (HCV) collaboration with a first-in-human study evaluating ABT-450, ...Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening
... HIV infection, who would be missed by traditional HIV antibody tests, according to research presented by Johns Hopkins University , Abbott ( NYSE: abt ) and others at the 16th Conference on Retroviruses and Opportunistic Infections (CROI). "Those with recent HIV infections who have not yet dev...Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
...ia, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products. About Abbott Abbott ( NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...USAID Selects Abt Associates to Lead Team in Strengthening Mexico Private Sector Competitiveness
CAMBRIDGE, Mass., March 11 /PRNewswire/ -- Abt Associates announced it has been awarded a 5-year, $17.8 million contract from the United States Agency for International Development (USAID) to lead a team of organizations in improving private sector competitiveness while protecting biodiversity in ...Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates
New Vice President Will lead Business Development and Communications for Company's International Line of Business CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Abt Associates announced that Valerie DeFillipo, a reproductive health and rights expert, has joined the company as Vice President for ...Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
Public Health Physician Spent Last 10 Years Helping Implement World Bank HIV/AIDS and Malaria Initiatives CAMBRIDGE, Mass., Jan. 8 /PRNewswire/ -- Abt Associates announced that Dr. John Osika has joined the company as a Principal Associate and HIV/AIDS and Infectious Disease Advisor. Dr. Osi...Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
CAMBRIDGE, Mass., Oct. 22 /PRNewswire/ -- Karen Walton-Bowen, M.Sc., C.Stat, a biostatistician with more than 20 years experience in the pharmaceutical and biotechnology industries, has joined Abt Bio-Pharma Solutions, Inc. (ABS), as Senior Director, Biometrics. An expert in clinical trials an...Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
Reflects Full Scope of Integrated Global Services CAMBRIDGE, Mass., April 1, 2008 /PRNewswire/ -- Abt Associates Clinical Trials today launches under a new name, Abt Bio-Pharma Solutions, Inc., a wholly owned subsidiary of Abt Associates Inc. The company will continue to provide cus...SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity...Abbott HIV Test Demonstrates Earlier Disease Detection
...h examples of first-of-a-kind diagnostic products and significant technological and research advancements. About Abbott Abbott (NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...Abbott to Present at Barclays Global Healthcare Conference
... ABBOTT PARK, Ill., Feb. 24 /PRNewswire-FirstCall/ -- Abbott ( NYSE: abt ) will present at the Barclays Global Healthcare Conference on Tuesday, March 10, 2009. Thomas C. Freyman, executive vice president, finance and chie...